Your browser doesn't support javascript.
loading
Metabolic Syndrome and Risk of Breast Cancer by Molecular Subtype: Analysis of the MEND Study.
Akinyemiju, Tomi; Oyekunle, Taofik; Salako, Omolola; Gupta, Anjali; Alatise, Olusegun; Ogun, Gabriel; Adeniyi, Adewale; Deveaux, April; Hall, Allison; Ayandipo, Omobolaji; Olajide, Thomas; Olasehinde, Olalekan; Arowolo, Olukayode; Adisa, Adewale; Afuwape, Oludolapo; Olusanya, Aralola; Adegoke, Aderemi; Tollefsbol, Trygve O; Arnett, Donna; Muehlbauer, Michael J; Newgard, Christopher B; Daramola, Adetola.
Afiliação
  • Akinyemiju T; Department of Population Health Sciences, School of Medicine, Duke University, Durham, NC; Duke Cancer Institute, School of Medicine, Duke University, Durham, NC; Duke Global Health Institute, Duke University, Durham, NC. Electronic address: tomi.akinyemiju@duke.edu.
  • Oyekunle T; Department of Population Health Sciences, School of Medicine, Duke University, Durham, NC.
  • Salako O; College of Medicine and Lagos University Teaching Hospital, University of Lagos, Lagos, Nigeria.
  • Gupta A; Department of Population Health Sciences, School of Medicine, Duke University, Durham, NC.
  • Alatise O; Obafemi Awolowo University Teaching Hospital, Ile-Ife, Osun State, Nigeria.
  • Ogun G; Unversity College Hospital, University of Ibadan, Ibadan, Oyo State, Nigeria.
  • Adeniyi A; Federal Medical Center, Abeokuta, Ogun State, Nigeria.
  • Deveaux A; Department of Population Health Sciences, School of Medicine, Duke University, Durham, NC.
  • Hall A; Department of Pathology, School of Medicine, Duke University, Durham, NC.
  • Ayandipo O; Unversity College Hospital, University of Ibadan, Ibadan, Oyo State, Nigeria.
  • Olajide T; College of Medicine and Lagos University Teaching Hospital, University of Lagos, Lagos, Nigeria.
  • Olasehinde O; Obafemi Awolowo University Teaching Hospital, Ile-Ife, Osun State, Nigeria.
  • Arowolo O; Obafemi Awolowo University Teaching Hospital, Ile-Ife, Osun State, Nigeria.
  • Adisa A; Obafemi Awolowo University Teaching Hospital, Ile-Ife, Osun State, Nigeria.
  • Afuwape O; Unversity College Hospital, University of Ibadan, Ibadan, Oyo State, Nigeria.
  • Olusanya A; Unversity College Hospital, University of Ibadan, Ibadan, Oyo State, Nigeria.
  • Adegoke A; Our Lady of Apostle Catholic Hospital, Ibadan, Oyo State, Nigeria.
  • Tollefsbol TO; University of Alabama at Birmingham, Birmingham, AL.
  • Arnett D; College of Public Health, University of Kentucky, Lexington, KY.
  • Muehlbauer MJ; Duke Molecular Physiology Institute, School of Medicine, Duke University, Durham, NC.
  • Newgard CB; Duke Molecular Physiology Institute, School of Medicine, Duke University, Durham, NC.
  • Daramola A; College of Medicine and Lagos University Teaching Hospital, University of Lagos, Lagos, Nigeria; University of Kansas Medical Center, Kansas City, KS.
Clin Breast Cancer ; 22(4): e463-e472, 2022 06.
Article em En | MEDLINE | ID: mdl-34980540
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Síndrome Metabólica / Neoplasias de Mama Triplo Negativas Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Síndrome Metabólica / Neoplasias de Mama Triplo Negativas Idioma: En Ano de publicação: 2022 Tipo de documento: Article